Richard J Perrin

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
    Richard J Perrin
    Division of Neuropathology, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS ONE 6:e16032. 2011
  2. ncbi YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
    Rebecca Craig-Schapiro
    Department of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Biol Psychiatry 68:903-12. 2010
  3. ncbi Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
    Rebecca Craig-Schapiro
    Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS ONE 6:e18850. 2011
  4. ncbi Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease
    Anne M Fagan
    Department of Neurology, Washington University School of Medicine, 660 South Euclid Ave, St Louis, MO 63110, USA
    Biomark Med 6:455-76. 2012
  5. ncbi Iatrogenic intradural epidermoid cyst after lumbar puncture. Case illustration
    Daniel Refai
    Department of Neurosurgery, Washington University, St. Louis Children's Hospital, Missouri 63110, USA
    J Neurosurg 106:322. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
    Richard J Perrin
    Division of Neuropathology, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS ONE 6:e16032. 2011
    ..To discover such biomarkers, we measured AD-associated changes in the cerebrospinal fluid (CSF) proteome...
  2. ncbi YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
    Rebecca Craig-Schapiro
    Department of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Biol Psychiatry 68:903-12. 2010
    ..Therefore, biomarkers that detect AD pathology in its early stages and predict dementia onset and progression will be invaluable for patient care and efficient clinical trial design...
  3. ncbi Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
    Rebecca Craig-Schapiro
    Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS ONE 6:e18850. 2011
    ..We utilized a targeted proteomics approach to discover novel cerebrospinal fluid (CSF) biomarkers that can augment the diagnostic and prognostic accuracy of current leading CSF biomarkers (Aβ42, tau, p-tau181)...
  4. ncbi Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease
    Anne M Fagan
    Department of Neurology, Washington University School of Medicine, 660 South Euclid Ave, St Louis, MO 63110, USA
    Biomark Med 6:455-76. 2012
    ..This article discusses the potential of several promising novel cerebrospinal fluid analytes, highlights the next steps critical for advancement in the field, and provides a prediction on how the field may evolve in 5-10 years...
  5. ncbi Iatrogenic intradural epidermoid cyst after lumbar puncture. Case illustration
    Daniel Refai
    Department of Neurosurgery, Washington University, St. Louis Children's Hospital, Missouri 63110, USA
    J Neurosurg 106:322. 2007